Ignite Creation Date:
2025-12-25 @ 3:21 AM
Ignite Modification Date:
2025-12-31 @ 11:11 PM
Study NCT ID:
NCT05748405
Status:
COMPLETED
Last Update Posted:
2024-10-10
First Post:
2023-01-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1/2 Trial of AEF0217 in Participants With Down Syndrome
Sponsor:
Aelis Farma
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-15
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-10-07
Completion Date Type:
ACTUAL
First Submit Date:
2023-01-11
First Submit QC Date:
None
Study First Post Date:
2023-02-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-08
Last Update Post Date:
2024-10-10
Last Update Post Date Type:
ACTUAL